Phase 3 trial underway for iopofosine I 131 in Waldenstrom's macroglobulinemia.
Cellectar Biosciences INC NEW (CLRB) News
Latest headlines that mention CLRB, newest first · each headline opens the original publisher
- Last price
- $1.21
- Day change
- -0.82%
- Next earnings
- 2026-11-12
CLRB headlines
latest coverageImage source: The Motley Fool. Thursday, May 14, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
CLRB news alerts
Get an alert by email or push when a new headline mentions CLRB.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.